Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M33,931Revenue (TTM) $M21,903Net Margin (%)1.5Altman Z-Score0.8
Enterprise Value $M74,019EPS (TTM) $0.1Operating Margin %9.8Piotroski F-Score3
P/E(ttm)587Beneish M-Score-2.3Pre-tax Margin (%)3.8Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %6.8Quick Ratio0.7Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %-4.8Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow7.7y-y EBITDA Growth Rate %-33.8ROA % (ttm)0.5Higher Current Ratio y-yN
Dividend Yield %3.9PEG--ROE % (ttm)0.2Less Shares Outstanding y-yN
Payout Ratio %1,943Shares Outstanding M1,015ROIC % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TEVA is held by these investors:



TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
    Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
    Naltrexone Showing More Potential in Drug Addiction Treatment Market Feb 05 2017 
    John Paulson's Bargain Stock Jan 30 2017 
    Teva: Good Value, Questionable Management? Jan 02 2017 
    Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
    4 Stocks Reach Their 3-Year Low Prices Dec 31 2016 
    10 for 2017! Investment Picks for the New Year Dec 23 2016 
    Teva Is a Hold Nov 30 2016 
    Buy Health Care Now? It All Depends on the Election Nov 07 2016 

    More From Other Websites
    Parsabiv Is Expected to Boost Amgen’s Revenues in 2017 Feb 17 2017
    David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017
    What's Driving Lilly's (LLY) Shares after 2016 Decline? Feb 16 2017
    Multinationals learn the limits of being big Feb 16 2017
    Teva Files 2016 Annual Report on Form 20-F Feb 15 2017
    Acorda Must Stave Off Mylan, Teva Generics To Protect Ampyra: RBC Feb 15 2017
    Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: 2016 By the Numbers : February 15,... Feb 15 2017
    Company News for February 14, 2017 Feb 14 2017
    Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q4, 2016 By the Numbers : February... Feb 14 2017
    Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Feb 14 2017
    Top Analyst Upgrades and Downgrades: Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva,... Feb 14 2017
    Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance Feb 14 2017
    [$$] Teva Swings to Loss on Write-Down But Beats Expectations Feb 14 2017
    Teva Maintains 2017 Guidance Despite Copaxone Patent Losses; Q4 Tops Feb 13 2017
    Troubling Trends Seen in Teva's FY16 Results Feb 13 2017
    How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More Feb 13 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)